Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies ; volume:75 ; number:5 ; day:21 ; month:8 ; year:2023 ; pages:1138-1151 ; date:10.2023
Pharmacological reports ; 75, Heft 5 (21.8.2023), 1138-1151, 10.2023

Classification: Medizin, Gesundheit

Creator: Jakimiuk, Alicja
Piechal, Agnieszka
Wiercińska-Drapało, Alicja
Nowaczyk, Alicja
Mirowska-Guzel, Dagmara

Contributor: SpringerLink (Online service)

DOI: 10.1007/s43440-023-00515-y

URN: urn:nbn:de:101:1-2023122316102157803784

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jakimiuk, Alicja
Piechal, Agnieszka
Wiercińska-Drapało, Alicja
Nowaczyk, Alicja
Mirowska-Guzel, Dagmara
SpringerLink (Online service)

Other Objects (12)

Clinical Observations on functional nervous Disorders

Therapie der Nervenkrankheiten : = Treatment of nervous disorders

Dolutegravir: Nutzenbewertung gemäß § 35a SGB V

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV

Anxiety disorders in acute central nervous system infections

Preclinical studies of low back pain

Creation of a long-acting nanoformulated dolutegravir

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

Extracellular vesicle therapy for traumatic central nervous system disorders

Probing disorders of the nervous system using reprogramming approaches

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report

Clinical Observations on functional nervous Disorders

Therapie der Nervenkrankheiten : = Treatment of nervous disorders

Dolutegravir: Nutzenbewertung gemäß § 35a SGB V

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV

Anxiety disorders in acute central nervous system infections

Preclinical studies of low back pain

Creation of a long-acting nanoformulated dolutegravir

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

Extracellular vesicle therapy for traumatic central nervous system disorders

Probing disorders of the nervous system using reprogramming approaches

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report

Clinical Observations on functional nervous Disorders

Therapie der Nervenkrankheiten : = Treatment of nervous disorders

Dolutegravir: Nutzenbewertung gemäß § 35a SGB V

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV

Anxiety disorders in acute central nervous system infections

Preclinical studies of low back pain

Creation of a long-acting nanoformulated dolutegravir

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

Extracellular vesicle therapy for traumatic central nervous system disorders

Probing disorders of the nervous system using reprogramming approaches

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Clinical Observations on functional nervous Disorders

Therapie der Nervenkrankheiten : = Treatment of nervous disorders

Dolutegravir: Nutzenbewertung gemäß § 35a SGB V

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV

Anxiety disorders in acute central nervous system infections

Preclinical studies of low back pain

Creation of a long-acting nanoformulated dolutegravir

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

Extracellular vesicle therapy for traumatic central nervous system disorders

Probing disorders of the nervous system using reprogramming approaches

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report

Clinical Observations on functional nervous Disorders

Therapie der Nervenkrankheiten : = Treatment of nervous disorders

Dolutegravir: Nutzenbewertung gemäß § 35a SGB V

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV

Anxiety disorders in acute central nervous system infections

Preclinical studies of low back pain

Creation of a long-acting nanoformulated dolutegravir

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

Extracellular vesicle therapy for traumatic central nervous system disorders

Probing disorders of the nervous system using reprogramming approaches

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report

Clinical Observations on functional nervous Disorders

Therapie der Nervenkrankheiten : = Treatment of nervous disorders

Dolutegravir: Nutzenbewertung gemäß § 35a SGB V

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV

Anxiety disorders in acute central nervous system infections

Preclinical studies of low back pain

Creation of a long-acting nanoformulated dolutegravir

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

Extracellular vesicle therapy for traumatic central nervous system disorders

Probing disorders of the nervous system using reprogramming approaches

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report

Related objects

Reset password